IDAC-Dose 2.1:基于ICRP成人参考体素模型的诊断核医学内照射剂量学程序
该文介绍了基于ICRP第133号出版物比吸收分数框架开发的IDAC-Dose2.1内照射剂量计算程序,使用ICRP第107号出版物核素衰变数据库,涵盖83个源区和47个靶组织,有效剂量按ICRP第60和103号出版物定义。程序经与DCAL程序验证,对131I-碘化物吸收剂量结果一致;并计算了18F-FDG、99mTc-高锝酸盐和131I-碘化物的有效剂量。
要点
- IDAC-Dose2.1基于ICRP第133号出版物成人参考体素模型框架开发,使用ICRP第107号出版物核素衰变数据。
- 程序涵盖83个源区照射47个靶组织,有效剂量按ICRP第60和103号出版物定义。
- 18F-FDG有效剂量为0.016 mSv/MBq,99mTc-高锝酸盐为0.014 mSv/MBq,131I-碘化物为16 mSv/MBq。
核心结论
- IDAC-Dose2.1内照射剂量学程序已开发,并应用于三种放射性药物以对照DCAL进行验证,以及利用ICRP计算体素模型的比吸收分数值生成改进的诊断核医学吸收剂量估算。
- 程序包含用于直径1 mm至9 cm球形结构及不同组织组成的吸收剂量计算子模块,以拓宽程序的临床实用性。
- IDAC-Dose2.1程序为免费研究软件,可在http://www.idac-dose.org下载。
研究设计与样本
- 基于ICRP第133号出版物中为参考成人给出的比吸收分数和内部剂量评估计算框架开发的内照射剂量学计算机程序。
- 程序使用ICRP第107号出版物的放射性核素衰变数据库,考虑83个不同源区照射47个靶组织,有效剂量按ICRP第60和103号出版物定义。
- 程序经与另一ICRP剂量学程序DCAL验证,DCAL在职业和环境放射性核素摄入评估中采用相同计算框架。
主要发现
- IDAC-Dose2.1确定的131I-碘化物吸收剂量和有效剂量经与剂量学程序DCAL验证,显示结果一致。
- 使用ICRP第103号出版物组织权重因子,18F-FDG每单位给药活度的有效剂量估计为0.016 mSv/MBq。
- 使用ICRP第103号出版物组织权重因子,99mTc-高锝酸盐每单位给药活度的有效剂量估计为0.014 mSv/MBq。
- 使用ICRP第103号出版物组织权重因子,131I-碘化物每单位给药活度的有效剂量估计为16 mSv/MBq。
- 针对九种特定α发射体,其衰变产物的吸收剂量贡献也纳入待积吸收剂量计算。
关键数值与推荐
- 18F-FDG静脉给药后使用ICRP第103号出版物组织权重因子的有效剂量为0.016 mSv/MBq。
- 99mTc-高锝酸盐口服给药后使用ICRP第103号出版物组织权重因子的有效剂量为0.014 mSv/MBq。
- 131I-碘化物口服给药后使用ICRP第103号出版物组织权重因子的有效剂量为16 mSv/MBq。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To date, the estimated radiation-absorbed dose to organs and tissues in patients undergoing diagnostic examinations in nuclear medicine is derived via calculations based on models of the human body and the biokinetic behaviour of the radiopharmaceutical. An internal dosimetry computer program, IDAC-Dose2.1, was developed based on the International Commission on Radiological Protection (ICRP)-specific absorbed fractions and computational framework of internal dose assessment given for reference adults in ICRP Publication 133. The program uses the radionuclide decay database of ICRP Publication 107 and considers 83 different source regions irradiating 47 target tissues, defining the effective dose as presented in ICRP Publications 60 and 103. The computer program was validated against another ICRP dosimetry program, Dose and Risk Calculation (DCAL), that employs the same computational framework in evaluation of occupational and environmental intakes of radionuclides. IDAC-Dose2.1 has a sub-module for absorbed dose calculations in spherical structures of different volumes and composition; this sub-module is intended for absorbed dose estimates in radiopharmaceutical therapy. For nine specific alpha emitters, the absorbed dose contribution from their decay products is also included in the committed absorbed dose calculations. RESULTS: The absorbed doses and effective dose of 131I-iodide determined by IDAC-Dose2.1 were validated against the dosimetry program DCAL, showing identical results. IDAC-Dose2.1 was used to calculate absorbed doses for intravenously administered 18F-FDG and orally administered 99mTc-pertechnetate and 131I-iodide, three frequently used radiopharmaceuticals. Using the tissue weighting factors from ICRP Publication 103, the effective dose per administered activity was estimated to be 0.016 mSv/MBq for 18F-FDG, 0.014 mSv/MBq for 99mTc-pertechnetate, and 16 mSv/MBq for 131I-iodide. CONCLUSIONS: The internal dosimetry program IDAC-Dose2.1 was developed and applied to three radiopharmaceuticals for validation against DCAL and to generate improved absorbed dose estimations for diagnostic nuclear medicine using specific absorbed fraction values of the ICRP computational voxel phantoms. The sub-module for absorbed dose calculations in spherical structures 1 mm to 9 cm in diameter and different tissue composition was included to broaden the clinical usefulness of the program. The IDAC-Dose2.1 program is free software for research and available for download at http://www.idac-dose.org .
引用
- Andersson M, Johansson L, Eckerman K, et al. IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms. EJNMMI Res. 2017. PMID: 29098485. doi:10.1186/s13550-017-0339-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。